{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-122823","form_type":"8-K","ticker":"LAB","cik":"0001162194","company_name":"STANDARD BIOTOOLS INC.","filed_at":"2024-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.813641+00:00","generated_at":"2026-05-30T03:18:12.587624+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Standard BioTools appoints Alex Kim as CFO; COO role eliminated","bullets":["Alex Kim appointed full-time CFO effective Nov 11, 2024; was interim CFO since Sept 1, 2024.","Kim previously served as COO; that position will be vacated after his CFO appointment.","Kim is a co-founder with nearly 30 years experience in healthcare and life sciences.","Jonathan Mickelsen named VP & Chief Accounting Officer.","No additional compensation for Kim in CFO role."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-122823","json":"https://secwatch.observer/filing/0000950170-24-122823.json","markdown":"https://secwatch.observer/filing/0000950170-24-122823.md","text":"https://secwatch.observer/filing/0000950170-24-122823.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1162194/000095017024122823/0000950170-24-122823-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1162194/000095017024122823/lab-20241106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T03:18:12.587624+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6a57529f77","claim":"Alex Kim was appointed as Chief Financial Officer at STANDARD BIOTOOLS INC..","evidence_excerpt":"On November 6, 2024, the Board of Directors of Standard BioTools Inc. (the “Company”) appointed Alex Kim, who has been serving as the Company’s Interim Chief Financial Officer since September 1, 2024, as the Company’s fulltime Chief Financial Officer, effective as of November 11, 2024 (the “Effective Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017024122823/0000950170-24-122823-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}